Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date

CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date U.S. Customs and Border Protection sent this bulletin at 10/28/2021 09:34 AM EDT CSMS #49912026 - Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Product Code End-date Due to duplication, the Food and Drug Administration (FDA) will be end-dating the Center for Drug Evaluation and Research (CDER) Product Code listed below. The product code below will be end-dated in 30 days. The end-date will be effective on November 28, 2021. End-Dated Code/Description 64O[][]06/Pembrolizumab, Monoclonal Antibodies Instead, please use the product code below. Product Code/Description 62Z[][]31/Pembrolizumab (Anti-Neoplastic - Part II) Please send any questions or concerns to the email address for the Product Code Builder Feedback: PCBFeedback@fda.hhs.gov For assistance with product code identification, the public may also refer to the FDA Product Code Builder .